Production and use of zinc amides

ABSTRACT

Compounds, methods of making the compounds and methods of using the compounds are generally described herein. The compounds are generally of formula R 1 R 2 N—ZnY LiY, wherein R 1  and R 2  are independently selected from H, aryl, heteroaryl containing one or more heteroatoms, alkyl, alkenyl, alkynyl, and silicon derivatives thereof; and each Y is independently selected from F, Cl, Br, I, CN, SCN, NCO, HalO 3 , HalO 4 , NO 3 , BF 4 , PF 6 , H, an alcoholate of formula OR 5 , a carboxylate of formula R 5 CO 2 ; a thiolate of formula SR 5 , R 5 P(O)O 2 , SCOR 5 , SCSR 5 , O n SR 5  and NO n , wherein n=2 or 3; wherein R 5  is selected from substituted or unsubstituted aryls or heteroaryls containing 3 to 24 carbon atoms and one or more heteroatoms selected from B, O, N, S, Se, P, linear, branched or cyclic, substituted or unsubstituted alkyls, alkenyls, alkynyls or H; and wherein Hal is a halogen selected from Cl, Br and I.

REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. application Ser. No. 13/147,339 filed Aug. 3, 2011, now U.S. Pat. No. 9,334,237, issued May 10, 2016, which in turn is a §371 application of PCT/EP2010/051677 filed Feb. 11, 2010, and claims priority from European Patent Application No. 09100112.3 filed Feb. 13, 2009.

BACKGROUND

Directed metalation of aromatic and heterocyclic compounds is an important method for the functionalization of these scaffolds. Lithium bases have been extensively used for performing the ortho-metalation of various unsaturated systems ((a) Snieckus, V. Chem. Rev. 1990, 90, 879. (b) Clayden, J.; Stimson, C. C.; Keenan M. Chem. Comm. 2006, 1393. (c) Schlosser M. Angew. Chem. Int. Ed. 2005, 44, 376. (d) Henderson, K. W.; Kerr, W. J. Chem. Eur. J. 2001, 3431. (e) Turck, A.; Plé, N.; Mongin, F.; Quéguiner, G. Tetrahedron 2001, 57, 4489. (f) Mongin F.; Quéguiner, G. Tetrahedron 2001, 57, 4059. (g) Levoux, F.; Jeschke, P.; Schlosser, M. Chem. Rev. 2005, 105, 827. (h) Kauch, M.; Hoppe, D. Synthesis 2006, 1578. (i) Clegg, W.; Dale, S. H.; Hevia, E.; Honeyman, G. W.; Mulvey R. E. Angew. Chem. Int. Ed. 2006, 45, 2371. (j) Hodgson, D. M.; Miles, S. M. Angew. Chem. Int. Ed. 2006, 45, 93. (k) Yus, M.; Foubelo, F. Handbook of Functionalized Organometallics, Knochel, P. Ed., Wiley-VCH: Weinheim, Germany 2005; Vol. 1, page 7). The use of magnesium bases, pioneered by Eaton, ((a) Eaton, P. E.; Martin, R. M. J. Org. Chem. 1988, 53, 2728. (b) Eaton, P. E.; Lee, C.-H.; Xiong, Y. J. Am. Chem. Soc. 1989, 111, 8016. (c) Eaton, P. E.; Lukin, K. A. J. Am. Chem. Soc. 1993, 115, 11370. (d) Zhang, M.-X.; Eaton, P. E. Angew. Chem. Int. Ed. 2002, 41, 2169) has recently found a renewed interest ((a) Hevia, E.; Honeyman, G. W.; Kennedy, A. R.; Mulvey, R. E.; Sherrington, D. C. Angew. Chem. Int. Ed. 2005, 44, 68. (b) Andrikopolous, P. C.; Armstrong, D. R.; Graham, D. V.; Hevia, E.; Kennedy, A. R.; Mulvey, R. E.; O'Hara, C. T.; Talmard, C. Angew. Chem. Int. Ed. 2005, 44, 3459. (c) Kondo, Y.; Akihiro, Y.; Sakamoto, T. J. Chem. Soc., Perkin Trans. 1 1996, 2331. (d) Shilai, M.; Kondo, Y.; Sakamoto, T. J. Chem. Soc., Perkin Trans. 1 2001, 442. (e) Bayh, O.; Awad, H.; Mongin, F.; Hoarau, C.; Bischoff, L.; Trécourt, F.; Quéguiner, G.; Marsais, F.; Blanco, F.; Abarca, B.; Ballesteros, R. J. Org. Chem. 2005, 70, 5190. (f) Eaton, P. E.; Zhang, M.-X.; Komiya, N.; Yang, C.-G.; Steele, I.; Gilardi, R. Synlett 2003, 9, 1275). Recently, lithium magnesiates ((a) Kitagawa, K.; Inoue, A.; Shinokubo, H.; Oshima, K. Angew. Chem. Int. Ed. 2000, 39, 2481. (b) Farkas, J.; Stoudt, S. J.; Hannawalt, E. M.; Pajeski, A. D.; Richey, H. G. Organometallics 2004, 23, 423. (c) Awad, H.; Mongin, F.; Trécourt, F.; Quéguiner, G.; Marsais, F.; Blanco, F.; Abarca, B.; Ballesteros, R. Tetrahedron Lett. 2004, 45, 6697; (a) Garcia-Alvarez, P.; Graham, D. V.; Hevia, E.; Kennedy, A. R.; Klett, J.; Mulvey, R. E.; O'Hara, C. T.; Weatherstone, S. Angew. Chem. Int. Ed. 2008, 47, 8079. (b) Mulvey, R. E. Organometallics 2006, 25, 1060. (c) Mulvey, R. E. Chem. Comm. 2001, 1049. (d) Westerhausen, M. Dalton Trans. 2006, 4755. (e) Mulvey, R. E.; Mongin, F.; Uchiyama, M.; Kondo, Y. Angew. Chem. Int. Ed., 2007, 46, 3802) have found useful synthetic applications. Mixed Mg/Li-bases of type R₂NMgCl.LiCl such as 2,2,6,6-tetramethylpiperidide magnesium chloride-lithium chloride (TMPMgCl.LiCl; Turbo-Hauser base) proved to be especially effective metalating agent, compatible with functional groups such as an ester, a nitrile or an aryl ketone ((a) Krasovskiy, A.; Krasovskaya, V.; Knochel, P. Angew. Chem. Int. Ed. 2006, 45, 2958. (b) Lin, W.; Baron, O.; Knochel, P. Org. Lett. 2006, 8, 5673. (c) Mosrin, M.; Knochel, P. Org. Lett. 2008, 10, 2497. (d) Mosrin, M.; Boudet, N.; Knochel, P. Org. Biomol. Chem. 2008, 6, 3237. (e) Clososki, G. C.; Rohbogner, C. J.; Knochel, P. Angew. Chem. Int. Ed. 2007, 46, 7681. (f) Rohbogner, C. J.; Clososki, G. C.; Knochel, P. Angew. Chem. Int. Ed. 2008, 47, 1503). However, more sensitive functionalities such as an aldehyde or a nitro group are not tolerated. Also sensitive heterocycles may undergo fragmentation ((a) Micetich, R. G. Can. J. Chem. 1970, 48, 2006. (b) Meyers, A. I.; Knaus, G. N. J. Am. Chem. Soc. 1974, 95, 3408. (c) Knaus, G. N.; Meyers, A. I. J. Org. Chem. 1974, 39, 1189. (d) Miller, R. A.; Smith, M. R.; Marcune, B. J. Org. Chem. 2005, 70, 9074. (e) Hilf, C.; Bosold, F.; Harms, K.; Marsch, M.; Boche, G. Chem. Ber. Rec. 1997, 130, 1213). Therefore a range of zinc amides have been reported which provide after metalation organozinc reagents compatible with most functionalities. In pioneer work, lithium di-tert-butyl-(2,2,6,6-tetra-methylpiperidino)zincate (Lit-Bu₂TMPZn) was reported by Kondo to be an excellent base for the zincation of various aromatics ((a) Micetich, R. G. Can. J. Chem. 1970, 48, 2006. (b) Meyers, A. I.; Knaus, G. N. J. Am. Chem. Soc. 1974, 95, 3408. (c) Knaus, G. N.; Meyers, A. I. J. Org. Chem. 1974, 39, 1189. (d) Miller, R. A.; Smith, M. R.; Marcune, B. J. Org. Chem. 2005, 70, 9074. (e) Hilf, C.; Bosold, F.; Harms, K.; Marsch, M.; Boche, G. Chem. Ber. Rec. 1997, 130, 1213). Unfortunately, the use of highly reactive zincates or related ate-bases ((a) Uchiyama, M.; Matsumoto, Y.; Nobuto, D.; Furuyama, T.; Yamaguchi, K.; Morokuma, K. J. Am. Chem. Soc. 2006, 128, 8748. (b) Clegg, W.; Dale, S. H.; Drummond, A. M.; Hevia, E.; Honeyman, G. W.; Mulvey, R. E. J. Am. Chem. Soc. 2006, 128, 7434. (c) Hevia, E.; Honeyman, G. W.; Mulvey, R. E. J. Am. Chem. Soc. 2005, 127, 13106. (d) Armstrong, D. R.; Clegg, W.; Dale, S. H.; Hevia, E.; Hogg, L. M.; Honeyman, G. W.; Mulvey, R. E. Angew. Chem. Int. Ed. 2006, 45, 3775. (e) Clegg, W.; Dale, S. H.; Harrington, R. W.; Hevia, E.; Honeyman, G. W.; Mulvey, R. E. Angew. Chem. Int. Ed. 2006, 45, 2374. (f) Naka, H.; Uchiyama, M.; Matsumoto, Y.; Wheatly, A. E. H.; McPartlin, M.; Morey, J. V.; Kondo, Y. J. Am. Chem. Soc. 2007, 129, 1921) is not compatible with sensitive functions such as an aldehyde or a nitro group. Recently, we have reported the preparation of a highly chemoselective base TMP₂Zn.2MgCl₂.2LiCl for the directed zincation of sensitive aromatics and heteroaromatics ((a) Wunderlich, S. H.; Knochel, P. Angew. Chem. Int. Ed. 2007, 46, 7685. (b) Mosrin, M.; Knochel P. Chem. Eur. J. 2009, DOI: 10.1002/chem.200801831). However, some electron-poor functionalized arenes and heteroarenes still give with this reagent, unsatisfactory results in terms of yields and reaction selectivity. Moreover, several activated aromatics or heteroaromatics like nitro derivatives or pyridazines require metalations below −50° C., which is not convenient for the reaction upscaling ((a) Wunderlich, S. H.; Knochel, P. Angew. Chem. Int. Ed. 2007, 46, 7685. (b) Mosrin, M.; Knochel P. Chem. Eur. J. 2009, DOI: 10.1002/chem.200801831; Wunderlich, S. H.; Knochel, P. Chem. Comm. 2008, 47, 6387).

SUMMARY OF THE INVENTION

Compounds, methods of making the compounds and methods of using the compounds are generally described herein. The compounds are generally of formula R¹R²N—ZnY LiY, wherein R¹ and R² are independently selected from H, aryl, heteroaryl containing one or more heteroatoms, alkyl, alkenyl, alkynyl, and silicon derivatives thereof; and each Y is independently selected from F, Cl, Br, I, CN, SCN, NCO, HalO₃, HalO₄, NO₃, BF₄, PF₆, H, an alcoholate of formula OR⁵, a carboxylate of formula R⁵CO₂; a thiolate of formula SR⁵, R⁵P(O)O₂, SCOR⁵, SCSR⁵, O_(n)SR⁵ and NO_(n), wherein n=2 or 3; wherein R⁵ is selected from substituted or unsubstituted aryls or heteroaryls containing 3 to 24 carbon atoms and one or more heteroatoms selected from B, O, N, S, Se, P, linear, branched or cyclic, substituted or unsubstituted alkyls, alkenyls, alkynyls or H; and wherein Hal is a halogen selected from Cl, Br and I.

DETAILED DESCRIPTION OF THE INVENTION

The inventive process for the preparation of a mixed Zn/Li amide comprises the reaction in a solvent a primary or secondary amine with a lithium alkyl.

In one or more embodiments, the inventive process includes a process for the preparation of a reagent having the general formula R¹R²N—ZnY LiY  (I) wherein R¹, R² are, independently, selected from H, substituted or unsubstituted aryl or heteroaryl containing one or more heteroatoms, linear, branched or cyclic, substituted or unsubstituted alkyl, alkenyl, alkynyl, or silicon derivatives thereof; and R¹ and R² together can be part of a cyclic or polymeric structure; and wherein at least one of R¹ and R² is other than H;

Y is selected from the group consisting of F; Cl; Br; I; CN; SCN; NCO; HaIO_(n), wherein n=3 or 4 and Hal is selected from Cl, Br and I; NO₃; BF₄; PF₆; H; a carboxylate of the general formula R⁵CO₂; an alcoholate of the general formula OR^(X); a thiolate of the general formula SR⁵; R⁵P(O)O₂; or SCOR⁵; or SCSR⁵; O_(n)SR⁵, wherein n=2 or 3; or NO_(n), wherein n=2 or 3; and a derivative thereof.

wherein R⁵ is a substituted or unsubstituted aryl or heteroaryl containing one or more heteroatoms, linear, branched or cyclic, substituted or unsubstituted alkyl, alkenyl, alkynyl, or derivatives thereof, or H;

and the reaction is carried out in a solvent of R¹R²N—H with R⁵Li in the presence of ZnY₂ and X is defined as Y above.

X and Y are independently or both Cl, Br or I, and preferably Cl. The lithium organyl reagent is sec-butyl-Li and the solvent is selected from cyclic, linear or branched mono or polyethers, thioethers, amines, phosphines, and derivatives thereof containing one or more additional heteroatoms selected from O, N, S and P, preferably tetrahydrofuran (THF), 2-methyltetrahydrofuran, dibutyl ether, diethyl ether, tert-butylmethy{umlaut over (ι)} ether, dimethoxyethane, dioxanes, preferably 1,4-dioxane, triethylamine, ethyldiisopropylamine, dimethyl sulfide, dibutylsulfide; cyclic amides, preferably N-methyl-2-pyrrolidone (NMP), N-ethyl-2-pyrrolidone (NEP), N-butyl-2-pyrrolidone (NBP); cyclic, linear or branched alkanes and/or alkenes wherein one or more hydrogens are replaced by a halogen, preferably dichloromethane, 1,2-dichloroethane, CCI₄; urea derivatives, preferably N,N′-dimethylpropyleneurea (DMPU); aromatic, hetero aromatic or aliphatic hydrocarbons, preferably benzene, toluene, xylene, pyridine, pentane, cyclohexane, hexane, heptane; hexamethylphosphorus triamide (HMPA), CS₂; or combinations thereof.

Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. All publications and other references mentioned herein are incorporated by reference in their entirety.

As used herein, the terms “alkyl”, “alkenyl” and “alkynyl” refer to linear, cyclic and branched, substituted and unsubstituted C₁-C₂₀ compounds. Preferred ranges for these compounds are C₁-C₁₀, preferably C₁-C₅ (lower alkyl) and C₂-C₁₀ and preferably C₂-C₅, respectively, for alkenyl and alkynyl. The term “cycloalkyl” generally refers to linear and branched, substituted and unsubstituted C₃-C₂₀ cycloalkanes. Here, preferred ranges are C₃-C₁₅, more preferably C₃-C₈.

Whenever any of the residues R¹, R², R³ and/or R⁴ are substituted by a substituent, the substituent may be selected by a person skilled in the art from any known substituent. A person skilled in the art will select a possible substituent according to his knowledge and will be able to select a substituent which will not interfere with other substituents present in the molecule and which will not interfere or disturb possible reactions, especially the reactions described within this application. Possible substituents include without limitation

-   -   halogens, preferably fluorine, chlorine, bromine and iodine;     -   aliphatic, alicyclic, aromatic or heteroaromatic hydrocarbons,         especially alkanes, alkylenes, arylenes, alkylidenes,         arylidenes, heteroarylenes and heteroarylidenes; carbonxylic         acids including the salts thereof;     -   carboxylic acid halides;     -   aliphatic, alicyclic, aromatic or heteroaromatic carboxylilc         acid esters;     -   aldehydes;     -   aliphatic, alicyclic, aromatic or heteroaromatic ketones;     -   alcohols and alcoholates, including a hydroxyl group;     -   phenoles and phenolates;     -   aliphatic, alicyclic, aromatic or heteroaromatic ethers;     -   aliphatic, alicyclic, aromatic or heteroaromatic peroxides;     -   hydroperoxides;     -   aliphatic, alicyclic, aromatic or heteroaromatic amides or         amidines;     -   nitriles;     -   aliphatic, alicyclic, aromatic or heteroaromatic amines;     -   aliphatic, alicyclic, aromatic or heteroaromatic imines;     -   aliphatic, alicyclic, aromatic or heteroaromatic sulfides         including a thiol group;     -   sulfonic acids including the salts thereof;     -   thioles and thiolates;     -   phosphonic acids including the salts thereof;     -   phosphinic acids including the salts thereof;     -   phosphorous acids including the salts thereof; phosphinous acids         including the salts thereof.

The substituents may be bound to the residues R¹, R², R³ and/or R⁴ via a carbon atom, an oxygen atom, a nitrogen atom, a sulfur atom, or a phosphorus atom. The hetero atoms in any structure containing hetero atoms, as e.g. heteroarylenes or heteroaromatics, may preferably be N, O, S and P.

When R¹ and R², or R³ and R⁴ can be part of a cyclic structure, it is to be understood that R¹ and R² together, or R³ and R⁴ together, are a divalent saturated or unsaturated, linear or branched alkyl, alkenyl or alkynyl which forms in connection with the nitrogen atom of the amide a cyclic secondary amide. An example of such a cyclic amide is the amide of TMPH.

Further, the residues R¹ and R², and/or R³ and R⁴ can be part of a polymeric structure. The nitrogen atom of the amide is the connected to a polymeric backbone which may even contain more than one nitrogen atom for the formation of an amide according to the invention.

The term “aryl” as used herein refers to substituted or unsubstituted C₄-C₂₄ aryl. By “heteroaryl”, a substituted or unsubstituted C₃-C₂₄aryl, containing one or more heteroatoms as B, O, N, S, Se, P, is meant. Preferred ranges for both are C₄-C₁₅, more preferably C₄-C₁₀, and includes aryls and fused aryls with or without heteroatoms, A preferred ring size comprises 5 or 6 ring atoms.

For example, we have explored the preparation of more selective zinc base which would allow chemoselective metalations at 25° C. for the directed zincation of sensitive aryl and heteroaryl substrates. The treatment of 2,2,6,6-tetramethylpiperidine (1; TMP-H) with n-BuLi (1.0 equiv, −40 to −10° C., 1 h) followed by the addition of ZnCl₂ (1.1 equiv, −10° C., 30 min) provides a ca. 1.3 M solution of TMPZnCl.LiCl (2), stable at room temperature (Scheme 1). In constrast to TMP₂Zn.2MgCl₂.2LiCl, this complex base showed a very good chemoselectivity for the zincation at 25° C. of various sensitive aromatics and heterocycles.

The inventive reagent could be used in a reaction with an electrophile preferably for the deprotonation of any substrate which can form stabilized or unstabilized carbanions.

Examples for the use of the reagent according to the invention are given in the following tables.

TABLE 1 Products Obtained by Regio- and Chemoselective Zincation of Diazines of Type 3, 6 and 9 with TMPZnCl•LiCl (2; 1.1 equiv; 25° C.) and Quenching with Electrophiles substrate of type 3, yield, entry 6 and 9 electrophile product %^(a) 1

I₂

84 2 3 4-fluorobenzoyl chloride

96^(b) 3 3

83^(c) 4

I₂

83 5 6 furoyl chloride

71^(b) 6 6 allyl bromide

89^(d) 7

I₂

90 8 9

87^(c) 9 9

72^(d) ^(a)Isolated, analytically pure product; ^(b)Transmetalation performed with 1.1 equiv of CuCN•2LiCl; ^(c)Obtained by palladium-catalyzed cross-coupling using Pd(dba)₂ (3 mol %) and (o-furyl)₃P (6 mol %); ^(d)Transmetalation performed with 5 mol % of CuCN•2LiCl.

Several sensitive heteroarenes such as pyridazines, (Wunderlich, S. H.; Knochel, P. Chem. Comm. 2008, 47, 6387) pyrimidines ((a) Turck, A.; Plé, N.; Quéguiner, G. Heterocycles 1990, 37, 2149. (b) Radinov, R.; Chaney, C.; Haimova, M. J. Org. Chem. 1991, 56, 4793 and pyrazines (Turck A.; Trohay, D.; Mojovic, L.; Plé, N.; Quéguiner, G. J. Organomet. Chem. 1991, 412, 301)) are cleanly zincated at 25° C. using the new base TMPZnCl.LiCl (2; Scheme 2 and Table 1). Thus, the treatment of 3,6-dichloropyridazine (3) with TMPZnCl.LiCl (2; 1.1 equiv, 25° C., 30 min) leads to the zincated species (4), which can be trapped with I₂, 4-fluorobenzoyl chloride (after transmetalation with CuCN.2LiCl) (Knochel, P.; Yeh, M. C. P.; Berk, S. C.; Talbert, J. J. Org. Chem. 1988, 53, 2390) or undergo a Negishi (Negishi, E.; Acc. Chem. Res. 1982, 15, 340) cross-coupling leading to the expected products 5a-c in 83-96% yields (entries 1-3 of Table 1). Zincations of other sensitive heteroaromatics can be readily achieved by the addition of TMPZnCl.LiCl (2). Thus, 4,6-dichloropyrimidine (6) is converted within 45 min at 25° C. to the 5-zincated species. Trapping with I₂ is furnishing the iodopyrimidine 8a in 83% yield (entry 4). Reaction with furoyl chloride (after transmetalation with CuCN.2LiCl) (Knochel, P.; Yeh, M. C. P.; Berk, S. C.; Talbert, J. J. Org. Chem. 1988, 53, 2390) provides the 5-ketopyrimidine 8b in 71% (entry 5). An allylation (after addition of CuCN.2LiCl) leads to the allyled derivative 8c in 89% (entry 6). Similarly, 2,6-dichloropyrazine (9) is zincated quantitatively with TMPZnCl.LiCl (2; 1.1 equiv, 25° C., 30 min) and reacted with iodine or undergoes a Negishi (Negishi, E.; Acc. Chem. Res. 1982, 15, 340) cross-coupling or an allylation with ethyl 2-(bromomethyl)acrylate (Villiéras, J.; Rambaud, M. Org. Synth. 1988, 66, 220) (after addition of CuCN.2LiCl) affording the expected products 11a-c in 72-90% yields (entries 7-9).

Other sensitive heterocycles such as purines ((a) Boudet, N; Dubbaka, S. R.; Knochel, P. Org. Lett. 2007, 10, 1715. (b) Tobrman, T.; Dvo{hacek over (r)}ák, D. Org. Lett. 2006, 8, 1291) can be metalated as well under mild conditions (Scheme 3). Thus, caffeine (12) (Do, H-Q; Kashif-Khan R. M.; Daugulis, O. J. Am. Chem. Soc. 2008, 130, 15185) undergoes a smooth zincation using TMPZnCl.LiCl (2; 1.1 equiv, 25° C., 5 min) furnishing the zinc species 13. Negishi (Negishi, E.; Acc. Chem. Res. 1982, 15, 340) cross-coupling or trapping with ethyl 2-(bromomethyl)acrylate (Villiéras, J.; Rambaud, M. Org. Synth. 1988, 66, 220) (after addition of CuCN.2LiCl) lead to the purine derivative 14a and 14b in 74 and 69% yields respectively.

A unique advantage of the zinc base 2 is that very sensitive functional groups such as a nitro group can be tolerated at 25° C. (I. Sapountzis, P. Knochel, Angew. Chem. Int. Ed. 2002, 41, 1610). Thus, 2,4-difluoronitrobenzene (15) was converted to the corresponding zinc reagent 16 by treatment with TMPZnCl.LiCl (2; 1.1 equiv, 25° C., 45 min). A Negishi (Negishi, E.; Acc. Chem. Res. 1982, 15, 340) cross-coupling can be readily performed to furnish the aryl derivative 17a in 92% yield (Scheme 4). Trapping with benzoyl chloride (after transmetalation with CuCN.2LiCl) (Knochel, P.; Yeh, M. C. P.; Berk, S. C.; Talbert, J. J. Org. Chem. 1988, 53, 2390) provides the ketone 17b in 84% yield. After trapping with I₂, the iodobenzene derivative 17c was obtained in 90% yield.

Other sensitive electron-poor arenes and heteroarenes are metalated as well using 2. Thus, 2-chloro-3-nitropyridine (18) undergoes smooth metalation with TMPZnCl.LiCl (2; 1.1 equiv, 25° C., 45 min) furnishing the zinc species 19. Trapping using 3-bromocyclohexene (after addition of CuCN.2LiCl) provides the pyridine 20 in 73% yield. Similarly, 4-fluoro-1-methoxy-2-nitrobenzene (21) was converted within 6 h at 25° C. to the corresponding zinc reagent 22. Quenching with ethyl 2-(bromomethyl)acrylate (Villiéras, J.; Rambaud, M. Org. Synth. 1988, 66, 220) (after addition of CuCN.2LiCl) leads to the allyled derivative 23 in 67% yield. Zincation of methyl 5-nitrofuran-2-carboxylate (24) can also be readily carried out using 2 (1.1 equiv) and furnishes the zinc species 25 in 30 min at 25° C. Allylation with 3-bromocyclohexene (after addition of CuCN.2LiCl) gives the furan 26 in 72% yield.

An aldehyde is also well tolerated ((a) Kneisel, F. F.; Dochnahl, M.; Knochel, P. Angew. Chem. Int. Ed. 2004, 43, 1017. (b) Gong, L.-Z.; Knochel, P. Synlett 2005), 267 Thus, benzo[b]thiophene-3-carbaldehyde (27) can be converted to the zinc species 28 at 25° C. using TMPZnCl.LiCl (2; 1.1 equiv) within 30 min. The formation of a subsequent carbon-carbon bond is also easily carried out by a Negishi (Negishi, E.; Acc. Chem. Res. 1982, 15, 340) cross-coupling and a Sonogashira ((a) Benderitter, P.; de Araujo, J. X. Jr.; Schmitt, M.; Bourguignon, J. J. Tetrahedron 2007, 63, 12465. (b) Kim, J. T.; Gevorgyan, V. Org. Lett. 2002, 4, 4697. (c) Sonogashira, K.; Tohda, Y.; Hagihara, N. Tetrahedron Lett. 1975, 50, 4467. (d) Sonogashira, K. Comprehensive Organic Synthesis Pergamon Press: New York, 1991, Vol. 3) reaction giving the aryl heterocycles 29a-c in 63-92% yield.

2) Experimental Procedures and Analytical Data

Typical Procedure 1: Preparation of the Reagent TMPZnCl.LiCl (2):

A dry and argon flushed 250 mL Schlenk-flask, equipped with a magnetic stirrer and a septum, was charged with freshly 2,2,6,6-tetramethylpiperidine (10.22 mL, 60 mmol) dissolved in THF (60 mL). This solution was cooled to −40° C. and n-BuLi (2.4 M in hexane, 25 mL, 60 mmol) was dropwise added. After the addition was complete, the reaction mixture was allowed to warm up slowly to −10° C. for 1 h. ZnCl₂ (1.0 M in THF, 66 mL, 66 mmol) was dropwise added and the resulting solution was stirred for 30 min at −10° C. and then for 30 min at 25° C. The solvents were then removed under vacuum affording a yellowish solid. Freshly distilled THF was then slowly added under vigorous stirring until the salts were completely dissolved. The freshly prepared TMPZnCl.LiCl (2) solution was titrated prior to use at 25° C. with benzoic acid using 4-(phenylazo)diphenylamine as indicator. A concentration of 1.3 M in THF was obtained.

Typical Procedure for the Zincation of Polyfunctionalized Aromatics and Heterocycles with TMPZnCl.LiCl (TP 2):

A dry and argon flushed 10 mL Schlenk-flask, equipped with a magnetic stirring bar and a septum was charged with the zinc base (2; 1.1 equiv). After setting the desired temperature (Table 1), a solution of the corresponding arene (1.0 mmol) in dry THF (2 mL) was dropwise added and stirred at the same temperature. The completion of the metalation was checked by GC-analysis of reaction aliquots quenched with a solution of I₂ in dry THF.

Synthesis of 3,6-dichloro-4-iodopyridazine (5a)

3,6-Dichloropyridazine (3) (149 mg, 1.0 mmol) in THF (2 mL) was added to a solution of TMPZnCl.LiCl (2) (1.3 M in THF, 0.85 mL, 1.1 mmol) at 25° C. and the reaction mixture was then stirred at this temperature for 30 min according to TP 2. I₂ (381 mg, 1.5 mmol) dissolved in dry THF (2 mL) was then dropwise added and the resulting mixture was stirred for 0.5 h. The reaction mixture was quenched with a sat. aq. Na₂S₂O₃ solution (10 mL) and with a sat. aq. NH₄Cl solution (20 mL), extracted with diethyl ether (3×50 mL) and dried over anhydrous Na₂SO₄. After filtration, the solvent was evaporated in vacuo. Purification by flash-chromatography (CH₂Cl₂/n-pentane, 1:2) furnished compound 5a (231 mg, 84%) as a colourless solid.

m.p.: 145.1-146.6° C.

¹H-NMR (300 MHz, CDCl₃) δ: 8.06 (s, 1H).

¹³C-NMR (75 MHz, CDCl₃) δ: 159.7, 153.9, 139.7, 105.4.

MS (70 eV, EI) m/z (%): 274 (95) [M⁺], 127 (23), 123 (10), 121 (10), 119 (100), 86 (15), 84 (43), 49 (8).

IR (ATR) {tilde over (v)} (cm⁻¹): 3092, 3020, 1796, 1516, 1488, 1464, 1332, 1296, 1276, 1236, 1152, 1136, 1060, 1044, 992, 956, 900, 812, 764, 728, 672, 660, 628, 608, 588, 564.

HRMS (EI) for C₄HCl₂IN₂ (273.8561): 273.8538.

Synthesis of (3,6-dichloropyridazin-4-yl)(4-fluorophenyl)methanone (5b)

3,6-Dichloropyridazine (3) (149 mg, 1.0 mmol) in THF (2 mL) was added to a solution of TMPZnCl.LiCl (2) (1.3 M in THF, 0.85 mL, 1.1 mmol) at 25° C. and the reaction mixture was then stirred at this temperature for 30 min according to TP 2. After cooling down to −20° C., CuCN.2LiCl (1.0 M in THF, 1.1 mmol, 1.1 equiv) was added and the resulting mixture was stirred for 30 min at this temperature. 4-Fluorobenzoyl chloride (317 mg, 2.0 mmol) was then slowly added and the resulting mixture was allowed to warm up slowly to 10° C. The reaction mixture was quenched with a sat. aq. NH₄Cl solution (20 mL), extracted with diethyl ether (3×50 mL) and dried over anhydrous Na₂SO₄. After filtration, the solvent was evaporated in vacuo. Purification by flash-chromatography (CH₂Cl₂/n-pentane, 1:1) furnished compound 5b (259 mg, 96%) as a white solid.

m.p.: 71.1-72.6° C.

¹H-NMR (400 MHz, CDCl₃) δ: 7.79-7.83 (m, 2H), 7.51 (s, 1H), 7.19-7.24 (m, 2H).

¹³C-NMR (100 MHz, CDCl₃) δ: 187.4, 167.0 (d, J (C—F)=259.9 Hz), 156.3, 151.5, 139.6, 132.8 (d, J (C—F)=9.9 Hz), 130.4 (d, J (C—F)=3.1 Hz), 127.7, 116.8 (d, J (C—F)=22.6 Hz).

MS (70 eV, EI) m/z (%): 270 (11) [M⁺], 123 (100), 95 (19).

IR (ATR) {tilde over (v)} (cm⁻¹): 3067, 2927, 2358, 1917, 1673, 1590, 1504, 1414, 1344, 1319, 1256, 1237, 1178, 1157, 1140, 1103, 1041, 1009, 967, 955, 909, 849, 841, 818, 795, 760, 753, 683, 659, 650, 645, 638, 633, 625, 620, 614, 606, 602.

HRMS (EI) for C₁₁H₅Cl₂FN₂O (269.9763): 269.9762.

Synthesis of 3,6-dichloro-4-(3-(trifluoromethyl)phenyl)pyridazine (5c)

3,6-Dichloropyridazine (3) (149 mg, 1.0 mmol) in THF (2 mL) was added to a solution of TMPZnCl.LiCl (2) (1.3 M in THF, 0.85 mL, 1.1 mmol) at 25° C. and the reaction mixture was then stirred at this temperature for 30 min according to TP 2. Pd(dba)₂ (17 mg, 3 mol %) and P(o-furyl)₃ (14 mg, 6 mol %) dissolved in THF (2 mL), and mixed with 3-iodobenzomethyltrifluoride (354 mg, 1.3 mmol, 1.3 equiv) were then transferred via cannula to the reaction mixture. The resulting mixture was stirred for 1 h at 25° C. The reaction mixture was then quenched with a sat. aq. NH₄Cl solution (20 mL), extracted with diethyl ether (3×50 mL) and dried over anhydrous Na₂SO₄. After filtration, the solvent was evaporated in vacuo. Purification by flash-chromatography (CH₂Cl₂/n-pentane, 1:2) furnished compound 5c (243 mg, 83%) as a colourless solid.

m.p.: 93.0-94.9° C.

¹H-NMR (400 MHz, CDCl₃) δ: 7.66-7.81 (m, 4H), 7.53 (s, 1H).

13C-NMR (100 MHz, CDCl3) δ: 156.1, 154.4, 143.3, 141.2, 133.9, 131.5 (q, J (C—F)=33.0 Hz), 129.6 (2), 128.3, 127.0 (q, J (C—F)=3.8 Hz), 125.7 (q, J (C—F)=3.8 Hz), 123.4 (q, J (C—F)=272.5 Hz).

MS (70 eV, EI) m/z (%): 294 (60), 292 (100) [M⁺], 266 (17), 264 (25), 229 (28), 206 (16), 204 (49), 194 (21), 169 (13), 138 (10), 136 (24), 113 (25), 59 (18).

IR (ATR) {tilde over (v)} (cm⁻¹): 3048, 2359, 1743, 1614, 1558, 1485, 1435, 1361, 1323, 1309, 1281, 1241, 1226, 1214, 1167, 1144, 1109, 1097, 1078, 1060, 1042, 1001, 933, 917, 903, 884, 803, 782, 755, 709, 697, 660, 645, 639, 632, 625, 620, 614, 606, 601.

HRMS (EI) for C₁₁H₅Cl₂F₃N₂ (291.9782): 291.9785.

Synthesis of 4,6-dichloro-5-iodo-pyrimidine (8a)

4,6-Dichloropyrimidine 6 (149 mg, 1.0 mmol) in THF (2 mL) was added to a solution of TMPZnCl.LiCl (2) (1.3 M in THF, 0.85 mL, 1.1 mmol) at 25° C. and the reaction mixture was then stirred at this temperature for 45 min according to TP 2. I₂ (381 mg, 1.5 mmol) dissolved in dry THF (2 mL) was then dropwise added and the resulting mixture was stirred for 0.5 h. The reaction mixture was quenched with a sat. aq. Na₂S₂O₃ solution (10 mL) and with a sat. aq. NH₄Cl solution (20 mL), extracted with diethyl ether (3×50 mL) and dried over anhydrous Na₂SO₄. After filtration, the solvent was evaporated in vacuo. Purification by flash-chromatography (CH₂Cl₂/n-pentane, 1:4) furnished compound 8a (227 mg, 83%) as a colourless solid.

m.p.: 134.9-136.5° C.

¹H NMR (300 MHz, CDCl₃) δ: 8.65 (s, 1H).

¹³C NMR (75 MHz, CDCl₃) δ: 166.6, 156.8, 98.9.

MS (70 eV, EI) m/z (%): 274 (100) [M⁺], 239 (27), 97 (12), 83 (12), 57 (21).

IR (ATR) {tilde over (v)} (cm⁻¹): 2923, 2855, 1900, 1499, 1386, 11341, 1296, 1214, 1080, 1014, 790, 763, 745.

HRMS (EI) for C₄HCl₂IN₂ (273.8561): 273.8565.

Synthesis of (4,6-dichloropyrimidin-5-yl)(furan-2-yl)methanone (8b)

4,6-Dichloropyrimidine 6 (149 mg, 1.0 mmol) in THF (2 mL) was added to a solution of TMPZnCl.LiCl (2) (1.3 M in THF, 0.85 mL, 1.1 mmol) at 25° C. and the reaction mixture was then stirred at this temperature for 45 min according to TP 2. CuCN.2LiCl (1.0 M solution in THF, 1.1 mL, 1.1 mmol) was slowly added at −20° C. and the reaction mixture was stirred at the same temperature for 30 min. Then, furan-2-carbonyl chloride (261 mg, 2.0 mmol) was dropwise added at −20° C. and the resulting mixture was allowed to warm up slowly to 25° C. overnight. The reaction mixture was quenched with a sat. aq. NH₄Cl solution (30 mL), extracted with diethyl ether (5×30 mL) and dried over anhydrous Na₂SO₄. After filtration, the solvent was evaporated in vacuo. Purification by flash-chromatography (CH₂Cl₂/n-pentane 1:1) furnished 8b as a colourless solid (172 mg, 71%).

m.p.: 143.6-145.4° C.

1H NMR (400 MHz, CDCl₃) δ: 8.88 (s, 1H), 7.70 (m, 1H), 7.28 (m, 1H), 6.66 (m, 1H).

13C NMR (100 MHz, CDCl₃) δ: 175.6, 158.8, 158.4, 150.8, 149.0, 130.9, 121.5, 113.5.

MS (70 eV, EI) m/z (%): 242 (48) [M⁺], 167 (49), 95 (100), 58 (21), 43 (33).

IR (ATR) {tilde over (v)} (cm⁻¹): 3133, 2969, 2359, 2340, 1738, 1636, 1558, 1540, 1512, 1450, 1403, 1375, 1361, 1297, 1230, 1216, 1168, 1123, 1083, 1032, 956, 904, 888, 878, 815, 789, 781, 746, 738, 668, 626, 615, 609.

HRMS (EI) for C₉H₄Cl₂N₂O₂ (241.9650): 241.9653.

Synthesis of 5-allyl-4,6-dichloropyrimidine (8c)

4,6-Dichloropyrimidine 6 (149 mg, 1.0 mmol) in THF (2 mL) was added to a solution of TMPZnCl.LiCl (2) (1.3 M in THF, 0.85 mL, 1.1 mmol) at 25° C. and the reaction mixture was then stirred at this temperature for 45 min according to TP 2. CuCN.2LiCl (1 in THF; 0.05 mL, 5 mol %) was then slowly added at −20° C. Allyl bromide (242 mg, 2.0 mmol) was then slowly added at −60° C. The resulting mixture was then allowed to warm up slowly to 0° C. for 4 h. The reaction mixture was quenched with a sat. aq. NH₄Cl solution (20 mL), extracted with diethyl ether (5×30 mL) and dried over anhydrous Na₂SO₄. After filtration, the solvent was evaporated in vacuo. Purification by flash-chromatography (CH₂Cl₂/n-pentane 1:2) furnished 8c as a colourless solid (215 mg, 89%).

¹H NMR (300 MHz, CDCl₃) δ: 8.64 (s, 1H), 5.80-5.90 (m, 1H), 5.09-5.18 (m, 2H), 3.64 (dt, ³J=6.4 Hz, ⁴J=1.4 Hz, 2H).

¹³C NMR (75 MHz, CDCl₃) δ: 162.0, 155.8, 130.9, 130.6, 118.2, 34.0.

MS (70 eV, EI) m/z (%): 188 (70) [M⁺], 125 (22), 117 (44), 90 (59), 64 (35), 49 (43), 41 (100).

IR (ATR) {tilde over (v)} (cm⁻¹): 2969, 2360, 1739, 1639, 1539, 1513, 1435, 1406, 1375, 1348, 1313, 1290, 1200, 1162, 1129, 1090, 989, 929, 906, 839, 777, 687, 668, 627, 621, 616.

HRMS (EI) for C₇H₆Cl₂N₂ (187.9908): 187.9913.

Synthesis of 3,5-dichloro-2-iodopyrazine (11a)

2,6-Dichloropyrazine (9) (149 mg, 1.0 mmol) in THF (2 mL) was added to a solution of TMPZnCl.LiCl (2) (1.3 M in THF, 0.85 mL, 1.1 mmol) at 25° C. and the reaction mixture was then stirred at this temperature for 30 min according to TP 2. I₂ (381 mg, 1.5 mmol) dissolved in dry THF (2 mL) was then dropwise added and the resulting mixture was stirred for 0.5 h. The reaction mixture was quenched with a sat. aq. Na₂S₂O₃ solution (10 mL) and with a sat. aq. NH₄Cl solution (20 mL), extracted with diethyl ether (3×50 mL) and dried over anhydrous Na₂SO₄. After filtration, the solvent was evaporated in vacuo. Purification by flash-chromatography (CH₂Cl₂/n-pentane, 1:2) furnished compound 11a (251 mg, 90%) as a colourless solid.

m.p.: 101.3-103.0° C.

¹H-NMR (300 MHz, CDCl₃) δ: 8.30 (s, 1H).

¹³C-NMR (75 MHz, CDCl₃) δ: 153.1, 146.9, 142.4, 115.7.

MS (70 eV, EI) m/z (%): 274 (100) [M⁺], 147 (75), 127 (18), 86 (32), 57 (21), 44 (94).

IR (ATR) {tilde over (v)} (cm⁻¹): 2969, 2633, 2281, 1784, 1738, 1510, 1491, 1379, 1353, 1323, 1274, 1230, 1217, 1205, 1175, 1162, 1143, 1018, 893, 843, 655, 634, 618, 611, 604.

HRMS (EI) for C₄HCl₂IN₂ (273.8561): 273.8555.

Synthesis of ethyl 4-(3,5-dichloropyrazin-2-yl)benzoate (11b)

2,6-Dichloropyrazine (9) (149 mg, 1.0 mmol) in THF (2 mL) was added to a solution of TMPZnCl.LiCl (2) (1.3 M in THF, 0.85 mL, 1.1 mmol) at 25° C. and the reaction mixture was then stirred at this temperature for 30 min according to TP 2. Pd(dba)₂ (17 mg, 3 mol %) and P(o-furyl)₃ (14 mg, 6 mol %) dissolved in THF (2 mL), followed by the addition of ethyl 4-iodobenzoate (359 mg, 1.3 mmol), were then transferred via cannula to the reaction mixture. The reaction mixture was stirred at 25° C. for 1.5 h. with a sat. aq. NH₄Cl solution (20 mL), extracted with diethyl ether (3×50 mL) and dried over anhydrous Na₂SO₄. After filtration, the solvent was evaporated in vacuo. Purification by flash-chromatography (CH₂Cl₂/n-pentane, 1:2) furnished compound 11b (251 mg, 87%) as a colourless solid.

m.p.: 88.5-90.0° C.

¹H-NMR (300 MHz, CDCl₃) δ: 8.59 (s, 1H), 8.14 (d, J=8.6 Hz, 2H), 7.84 (d, J=8.6 Hz, 2H), 4.40 (q, J=7.2 Hz, 2H), 1.40 (t, J=7.0 Hz, 3H).

13C-NMR (75 MHz, CDCl₃) δ: 165.8, 150.1, 145.9, 142.0, 139.0, 131.6, 129.4 (2), 61.2, 14.3.

MS (70 eV, EI) m/z (%): 296 (32) [M⁺], 270 (24), 268 (38), 251 (100), 223 (26).

IR (ATR) {tilde over (v)} (cm⁻¹): 3086, 3005, 2985, 2359, 1966, 1708, 1611, 1569, 1537, 1507, 1482, 1466, 1446, 1423, 1408, 1366, 1310, 1283, 1263, 1190, 1175, 1140, 1131, 1114, 1098, 1028, 1021, 1009, 915, 858, 843, 786, 758, 719, 698, 657, 634, 621, 616, 610, 602.

HRMS (EI) for C₁₃H₁₀Cl₂N₂O₂ (296.0119): 296.0119.

Synthesis of ethyl 2-((3,5-dichloropyrazin-2-yl)methyl)acrylate (11c)

2,6-Dichloropyrazine (9) (149 mg, 1.0 mmol) in THF (2 mL) was added to a solution of TMPZnCl.LiCl (2) (1.3 M in THF, 0.85 mL, 1.1 mmol) at 25° C. and the reaction mixture was then stirred at this temperature for 30 min according to TP 2. After cooling down to −50° C., ethyl 2-(bromomethyl)acrylate (230 mg, 1.2 mmol) and CuCN.2LiCl (1.0 M solution in THF, 5 drops) were added and the resulting mixture was allowed to warm up slowly to −20° C. The reaction mixture was quenched with a sat. aq. NH₄Cl solution (20 mL), extracted with diethyl ether (3×50 mL) and dried over anhydrous Na₂SO₄. After filtration, the solvent was evaporated in vacuo. Purification by flash-chromatography (CH₂Cl₂/n-pentane, 1:3) furnished compound 11c (187 mg, 72%) as a colourless oil.

1H-NMR (300 MHz, CDCl₃) δ: 8.38 (s, 1H), 6.34 (s, 1H), 5.56 (s, 1H), 4.14 (q, J=7.1 Hz, 2H), 3.92 (s, 2H), 1.21 (t, J=7.1 Hz, 3H).

¹³C-NMR (75 MHz, CDCl₃) δ: 166.0, 151.5, 146.8, 145.0, 141.5, 136.0, 127.6, 60.9, 36.7, 14.0.

MS (70 eV, EI) m/z (%): 261 (100) [M⁺41], 163 (10).

IR (ATR) {tilde over (v)} (cm⁻¹): 2969, 2359, 1738, 1503, 1385, 1342, 1294, 1226, 1215, 1084, 1013, 987, 954, 795, 764, 749, 667, 621, 615, 608, 603.

HRMS (ESI) for C₁₀H₁₀Cl₂N₂O₂ (260.0119 (M⁺-H)): 261.0196.

Synthesis of 8-(4-chlorophenyl)-1,3,7-trimethyl-1H-purine-2,6(3H,7H)-dione (14a)

TMPZnCl.LiCl (2) (1.3 M in THF, 0.85 mL, 1.1 mmol) was added to a solution of 1,3,7-trimethyl-1H-purine-2,6(3H,7H)-dione (12) (194 mg, 1.0 mmol) in THF (2 mL) at 25° C. and the reaction mixture was then stirred at this temperature for max. 5 min. Pd(dba)₂ (17 mg, 3 mol %) and P(o-furyl)₃ (14 mg, 6 mol %) dissolved in THF (2 mL), and mixed with 1-chloro-4-iodobenzene (310 mg, 1.3 mmol, 1.3 equiv) were then transferred via cannula to the reaction mixture. The resulting mixture was stirred for 1 h at 25° C. The reaction mixture was then quenched with a sat. aq. NH₄Cl solution (20 mL), extracted with diethyl ether (3×50 mL) and dried over anhydrous Na₂SO₄. After filtration, the solvent was evaporated in vacuo. Purification by flash-chromatography (CH₂Cl₂/ether, 1:1) furnished compound 14a (226 mg, 74%) as a colourless solid.

¹H-NMR (300 MHz, CDCl₃) δ: 7.62 (d, J=8.5 Hz, 2H), 7.48 (d, J=8.5 Hz, 2H), 4.03 (s, 3H), 3.59 (s, 3H), 3.39 (s, 3H).

¹³C-NMR (75 MHz, CDCl₃) δ: 155.4, 151.5, 150.7, 148.1, 136.7, 130.4, 129.2, 126.7, 108.6, 33.9, 29.8, 28.0.

MS (70 eV, EI) m/z (%): 304 (100) [M⁺], 82 (23), 67 (13).

IR (ATR) {tilde over (v)} (cm⁻¹): 2969, 1738, 1694, 1646, 1605, 1569, 1538, 1473, 1454, 1430, 1408, 1374, 1288, 1229, 1216, 1180, 1108, 1090, 1074, 1030, 1008, 977, 835, 803, 759, 749, 739, 730, 708, 685, 671, 650, 645, 639, 632, 625, 620, 614, 606. 601.

HRMS (ESI) for C₁₄H₁₃ClN₄O₂ (304.0727): 304.0722.

Synthesis of ethyl 2-((1,3,7-trimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)methyl)acrylate (14b)

TMPZnCl.LiCl (2) (1.3 M in THF, 0.85 mL, 1.1 mmol) was added to a solution of 1,3,7-trimethyl-1H-purine-2,6(3H,7H)-dione (12) (194 mg, 1.0 mmol) in THF (2 mL) at 25° C. and the reaction mixture was then stirred at this temperature for max. 5 min. After cooling down to −50° C., ethyl 2-(bromomethyl)acrylate (230 mg, 1.2 mmol) and CuCN.2LiCl (1.0 M solution in THF, 5 drops) were added and the resulting mixture was allowed to warm up slowly overnight. The reaction mixture was quenched with a sat. aq. NH₄Cl solution (20 mL), extracted with diethyl ether (3×50 mL) and dried over anhydrous Na₂SO₄. After filtration, the solvent was evaporated in vacuo. Purification by flash-chromatography (CH₂Cl₂/ether, 1:1) furnished compound 14b (211 mg, 69%) as a colourless solid.

1H-NMR (300 MHz, CDCl₃) δ: 6.28 (s, 1H), 5.49 (s, 1H), 4.14 (q, J=7.1 Hz, 2H), 3.86 (s, 3H), 3.70 (s, 2H), 3.45 (s, 3H), 3.29 (s, 3H), 1.21 (t, J=7.1 Hz, 3H).

13C-NMR (75 MHz, CDCl₃) δ: 165.7, 155.1, 151.4, 150.8, 147.7, 135.0, 127.3, 107.4, 61.1, 31.8, 29.6, 29.3, 27.7, 14.0.

MS (70 eV, EI) m/z (%): 306 (78) [M⁺], 260 (28), 232 (100), 219 (11), 67 (13).

IR (ATR) {tilde over (v)} (cm⁻¹): 2998, 2956, 2358, 1719, 1697, 1658, 1548, 1497, 1448, 1426, 1402, 1362, 1340, 1293, 1253, 1215, 1162, 1112, 1033, 978, 960, 939, 894, 858, 831, 812, 759, 743, 718, 693, 663, 641, 630, 602.

HRMS (ESI) for C₁₄H₁₈N₄O₄ (306.1328): 306.1320.

Synthesis of ethyl 2′,6′-difluoro-3′-nitrobiphenyl-4-carboxylate (17a)

2,4-Difluoro-1-nitrobenzene 15 (159 mg, 1.0 mmol) in THF (2 mL) was added to a solution of TMPZnCl.LiCl (2) (1.3 M in THF, 0.85 mL, 1.1 mmol) at 25° C. and the reaction mixture was then stirred at this temperature for 45 min according to TP 2. Pd(dba)₂ (17 mg, 3 mol %) and P(o-furyl)₃ (14 mg, 6 mol %) dissolved in THF (2 mL), followed by the addition of ethyl 4-iodobenzoate (359 g, 1.3 mmol), were then transferred via cannula at −20° C. The resulting mixture was allowed to warm up slowly to 25° C. overnight. The reaction mixture was then quenched with a sat. aq. NH₄Cl solution (20 mL), extracted with diethyl ether (3×50 mL) and dried over anhydrous Na₂SO₄. After filtration, the solvent was evaporated in vacuo. Purification by flash-chromatography (CH₂Cl₂/n-pentane, 1:2) furnished compound 17a (281 mg, 92%) as a colourless solid.

m.p.: 85.0-86.7° C.

¹H NMR (300 MHz, CDCl₃) δ: 8.09-8.18 (m, 1H), 8.15 (d, J=8.8 Hz, 2H), 7.51 (d, J=8.8 Hz, 2H), 7.11-7.18 (m, 1H), 4.40 (q, J=7.0 Hz, 3H), 1.40 (d, J=7.0 Hz, 2H).

¹³C NMR (75 MHz, CDCl₃) δ: 165.8, 162.5 (dd, J=6.0 Hz, J=260.1 Hz), 153.7 (dd, J=6.0 Hz, J=260.1 Hz), 131.2 (dd, J=0.5 Hz, J=3.9 Hz), 130.2 (dd, J=1.8 Hz, J=2.0 Hz), 129.7, 126.6 (dd, J=1.8 Hz, J=21.4 Hz), 120.2 (dd, J=28.1 Hz, J=1.8 Hz), 112.1 (dd, J=4.3 Hz, J=24.7 Hz), 61.3, 14.3.

MS (70 eV, EI) m/z (%): 307 (23) [M⁺], 279 (48), 262 (100), 216 (43), 188 (34), 44 (12).

IR (ATR) {tilde over (v)} (cm⁻¹): 3101, 2969, 2359, 1712, 1621, 1589, 1567, 1535, 1510, 1472, 1404, 1368, 1341, 1304, 1286, 1269, 1215, 1185, 1170, 1148, 1127, 1103, 1070, 1020, 1011, 948, 879, 857, 824, 778, 756, 714, 702, 667, 636, 620, 607, 602.

HRMS (EI) for C₁₅H₁₁F₂NO₄ (307.0656): 307.0651.

Synthesis of (2,6-difluoro-3-nitrophenyl)(phenyl)methanone (17b)

2,4-Difluoro-1-nitrobenzene 15 (159 mg, 1.0 mmol) in THF (2 mL) was added to a solution of TMPZnCl.LiCl (2) (1.3 M in THF, 0.85 mL, 1.1 mmol) at 25° C. and the reaction mixture was then stirred at this temperature for 45 min according to TP 2. CuCN.2LiCl (1.0 M solution in THF, 1.1 mL, 1.1 mmol) was slowly added at −40° C. and the reaction mixture was stirred at the same temperature for 30 min. Then, benzoyl chloride (281 mg, 2.0 mmol) was added dropwise at −40° C. and the resulting mixture was allowed to warm up slowly to 25° C. overnight. The reaction mixture was then quenchend with a sat. aq. NH₄Cl solution (20 mL), extracted with diethyl ether (3×50 mL) and dried over anhydrous Na₂SO₄. After filtration, the solvent was evaporated in vacuo. Purification by flash-chromatography (CH₂Cl₂/n-pentane, 1:2) furnished compound 17b (221 mg, 84%) as a colourless solid.

m.p.: 75.8-77.2° C.

1H NMR (300 MHz, CDCl₃) δ: 7.14-8.31 (m, 7H).

¹³C NMR (75 MHz, CDCl₃) δ: 186.2, 162.2 (dd, J=4.2 Hz, J=262.4 Hz), 153.7 (dd, J=9.0 Hz, J=269.9 Hz), 135.7, 135.1, 133.8, 130.2, 129.6, 129.1, 128.7 (dd, J=2.1 Hz, J=10.9 Hz), 128.5, 119.3 (dd, J=21.9 Hz, J=2.1 Hz).

MS (70 eV, EI) m/z (%): 263 (52) [M⁺], 105 (100), 33 (77).

IR (ATR) {tilde over (v)} (cm⁻¹): 3100, 1912, 1738, 1675, 1619, 1594, 1530, 1496, 1469, 1450, 1351, 1320, 1311, 1280, 1266, 1217, 1180, 1159, 1128, 1100, 1073, 1034, 1027, 1000, 970, 934, 862, 834, 828, 797, 774, 759, 731, 705, 692, 683, 668, 645, 638, 630, 626, 620, 614, 606, 601.

HRMS (EI) for C₁₃H₇F₂NO₃ (263.0394): 263.0393.

Synthesis of 1,3-difluoro-2-iodo-4-nitrobenzene (17c)

2,4-Difluoro-1-nitrobenzene 15 (159 mg, 1.0 mmol) in THF (2 mL) was added to a solution of TMPZnCl.LiCl (2) (1.3 M in THF, 0.85 mL, 1.1 mmol) at 25° C. and the reaction mixture was then stirred at this temperature for 45 min according to TP 2. I₂ (381 mg, 1.5 mmol) dissolved in dry THF (2 mL) was then dropwise added and the resulting mixture was stirred for 0.5 h. The reaction mixture was quenched with a sat. aq. Na₂S₂O₃ solution (10 mL) and with a sat. aq. NH₄Cl solution (20 mL), extracted with diethyl ether (3×50 mL) and dried over anhydrous Na₂SO₄. After filtration, the solvent was evaporated in vacuo. Purification by flash-chromatography (CH₂Cl₂/n-pentane, 1:1) furnished compound 17c (256 mg, 90%) as a colourless solid.

m.p.: 46.1-47.5° C.

¹H NMR (300 MHz, CDCl₃) δ: 8.12-8.17 (m, 1H), 7.04-7.08 (m, 1H).

¹³C NMR (75 MHz, CDCl₃) δ: 165.6 (dd, J=5.0 Hz, J=252.6 Hz), 156.4 (dd, J=6.9 Hz, J=264.1 Hz), 127.7 (dd, J=2.3 Hz, J=10.3 Hz), 111.6 (dd, J=4.2 Hz, J=26.1 Hz), 74.3 (dd, J=29.2 Hz, J=1.9 Hz).

MS (70 eV, EI) m/z (%): 285 (100) [M⁺], 258 (17), 239 (19), 227 (17), 167 (25), 149 (66), 112 (58), 71 (11), 57 (12), 44 (12).

IR (ATR) {tilde over (v)} (cm⁻¹): 3098, 2926, 2855, 2359, 1916, 1739, 1602, 1584, 1529, 1463, 1425, 1336, 1301, 1277, 1218, 1147, 1105, 1011, 860, 827, 751, 698, 669, 621, 616.

HRMS (EI) for C₆H₂F₂INO₂ (284.9098): 284.9094.

Synthesis of 2-chloro-4-cyclohex-2-enyl-3-nitro-pyridine (20)

2-Chloro-3-nitropyridine (18) (159 mg, 1.0 mmol) in THF (2 mL) was added to a solution of TMPZnCl.LiCl (2) (1.3 M in THF, 0.85 mL, 1.1 mmol) at 25° C. and the reaction mixture was then stirred at this temperature for 30 min according to TP 2. After cooling down to −50° C., 3-bromo-cyclohexene (192 mg, 1.2 mmol) and CuCN.2LiCl (1.0 M solution in THF, 0.05 mL, 0.05 mmol) were added and the reaction mixture was stirred for 1 h at the same temperature. The reaction mixture was quenched with a sat. aq. NH₄Cl solution (20 mL), extracted with diethyl ether (3×50 mL) and dried over anhydrous Na₂SO₄. After filtration, the solvent was evaporated in vacuo. Purification by flash-chromatography (CH₂Cl₂/n-pentane, 1:1) furnished 2-chloro-4-cyclohex-2-enyl-3-nitro-pyridine (20) (173 mg, 73%) as a colourless solid.

m.p.: 54.5-55.4° C.

¹H-NMR (300 MHz, CDCl₃) δ: 8.44 (d, ³J=5.1 Hz, 1H), 7.32 (d, ³J=5.1 Hz, 1H), 6.07 (ddd, ³J=10.0 Hz, ³J=6.1 Hz, ⁴J=3.7 Hz, 1H), 5.54 (dd, ³J=10.0, ⁴J=1.9 Hz, 1H), 3.46 (m, 1H), 2.09 (m, 3H), 1.76 (m, 1H), 1.64 (m, 1H), 1.51 (m, 1H).

¹³C-NMR (75 MHz, CDCl₃) δ: 150.2, 150.0, 146.5, 141.8, 131.9, 125.9, 123.3, 37.4, 31.3, 24.7, 20.8.

MS (70 eV, EI) m/z (%): 237 (3) [M⁺-H], 223 (31), 221 (100), 203 (48), 193 (48), 185 (20), 181 (45), 167 (32), 165 (31), 157 (21), 129 (29), 128 (31), 115 (21), 77 (35), 51 (22), 41 (34).

IR (ATR) {tilde over (v)} (cm⁻¹): 2939, 1589, 1539, 1446, 1361, 1347, 1231, 1137, 1041, 973, 918, 890, 855, 845, 757, 723, 691, 616.

HRMS (EI) for C₁₁H₁₁ClN₂O₂ (237.0431 [M⁺-H]): 237.0424 [M⁺-H].

Synthesis of ethyl 2-(6-fluoro-3-methoxy-2-nitrobenzyl)acrylate (23)

4-Fluoro-1-methoxy-2-nitrobenzene (21) (171 mg, 1.0 mmol) in THF (2 mL) was added to a solution of TMPZnCl.LiCl (2) (1.3 M in THF, 0.85 mL, 1.1 mmol) at 25° C. and the reaction mixture was then stirred at this temperature for 6 h according to TP 2. After cooling down to −50° C., ethyl 2-(bromomethyl)acrylate (230 mg, 1.2 mmol) and CuCN.2LiCl (1.0 M solution in THF, 5 drops) were added at −40° C. and the resulting mixture was stirred at the same temperature for 1 h. The reaction mixture was quenched with a sat. aq. NH₄Cl solution (20 mL), extracted with diethyl ether (3×50 mL) and dried over anhydrous Na₂SO₄. After filtration, the solvent was evaporated in vacuo. Purification by flash-chromatography (CH₂Cl₂/n-pentane, 1:3) furnished compound 23 (189 mg, 67%) as a colourless oil.

1H-NMR (300 MHz, CDCl₃) δ: 7.15 (m, 1H), 8.89-8.93 (m, 1H), 6.24 (s, 1H), 5.31 (s, 1H), 4.19 (q, J=7.1 Hz, 2H), 3.86 (s, 3H), 3.63 (bs, 2H), 1.27 (t, J=7.1 Hz, 3H).

13C-NMR (75 MHz, CDCl₃) δ: 165.9, 154.3 (d, J=243.6 Hz), 147.1 (d, J=2.8 Hz), 136.2 (d, J=0.8 Hz), 126.3 (d, J=0.8 Hz), 120.0 (d, J=21.9 Hz), 117.6, 117.3, 111.7 (d, J=8.3 Hz), 61.1, 56.7, 26.9 (d, J=2.9 Hz), 14.1.

MS (70 eV, EI) m/z (%): 283 (1) [M⁺], 237 (100), 209 (88), 192 (58), 166 (20), 149 (21), 133 (16), 121 (13), 99 (11).

IR (ATR) {tilde over (v)} (cm⁻¹): 2969, 2359, 1738, 1503, 1385, 1342, 1294, 1226, 1215, 1084, 1013, 987, 954, 795, 764, 749, 667, 621, 615, 608, 603.

HRMS (ESI) for C₁₃H₁₄FNO₅ (283.0856): 283.0845.

Synthesis of methyl 3-(cyclohex-2-enyl)-5-nitrofuran-2-carboxylate (26)

Methyl 5-nitrofuran-2-carboxylate (24) (171 mg, 1.0 mmol) in THF (2 mL) was added to a solution of TMPZnCl.LiCl (2) (1.3 M in THF, 0.85 mL, 1.1 mmol) at 25° C. and the reaction mixture was then stirred at this temperature for 30 min according to TP 2. After cooling down to −50° C., 3-bromocyclohexene (209 mg, 1.3 mmol) and CuCN.2LiCl (1.0 M solution in THF, 5 drops) were added and the resulting mixture was stirred for 1 h at this temperature. The reaction mixture was quenched with a sat. aq. NH₄Cl solution (20 mL), extracted with diethyl ether (3×50 mL) and dried over anhydrous Na₂SO₄. After filtration, the solvent was evaporated in vacuo. Purification by flash-chromatography (CH₂Cl₂/n-pentane, 1:2) furnished compound 26 (179 mg, 72%) as a yellowish oil.

¹H-NMR (400 MHz, CDCl₃) δ: 7.20 (s, 1H), 5.94 (m, 1H), 5.56 (m, 1H), 4.10 (m, 1H), 3.92 (s, 3H), 2.07 (m, 3H), 1.50-1.69 (m, 3H).

¹³C-NMR (100 MHz, CDCl₃) δ: 157.5, 142.6, 133.9, 130.4, 126.2, 120.1, 52.8, 32.2, 29.0, 24.6, 20.5.

MS (70 eV, EI) m/z (%): 252 (2) [M⁺], 234 (100), 217 (55), 146 (10).

IR (ATR) {tilde over (v)} (cm⁻¹): 2936, 2356, 1729.35, 1629, 1594, 1532, 1502, 1435, 1398, 1338, 1288, 1226, 1206, 1110, 1091, 985, 925, 880, 848, 819, 799, 763, 725, 668, 634, 622.

HRMS (EI) for C₁₂H₁₃NO₅ (251.0794): 251.0794.

Synthesis of 2-(3-(trifluoromethyl)phenyl)benzo[b]thiophene-3-carbaldehyde (29a)

Benzo[b]thiophene-3-carbaldehyde (27) (162 mg, 1.0 mmol) in THF (2 mL) was added to a solution of TMPZnCl.LiCl (2) (1.3 M in THF, 0.85 mL, 1.1 mmol) at 25° C. and the reaction mixture was then stirred at this temperature for 30 min according to TP 2. Pd(dba)₂ (17 mg, 3 mol %) and P(o-furyl)₃ (14 mg, 6 mol %) dissolved in THF (2 mL), and mixed with 3-iodobenzomethyltrifluoride (354 mg, 1.3 mmol, 1.3 equiv) were then transferred via cannula to the reaction mixture. The resulting mixture was stirred for 1 h at 25° C. The reaction mixture was then quenched with a sat. aq. NH₄Cl solution (20 mL), extracted with diethyl ether (3×50 mL) and dried over anhydrous Na₂SO₄. After filtration, the solvent was evaporated in vacuo. Purification by flash-chromatography (CH₂Cl₂/n-pentane, 1:3) furnished compound 29a (281 mg, 92%) as a colourless solid.

m.p.: 102.8-104.2° C.

¹H-NMR (400 MHz, CDCl₃) δ: 10.02 (s, 1H), 8.79 (m, 1H), 7.45-7.87 (m, 7H).

¹³C-NMR (100 MHz, CDCl₃) δ: 185.9, 158.0, 138.0, 136.8, 133.7, 132.4, 131.5 (q, J (C—F)=33.0 Hz), 130.7, 129.5, 127.0 (q, J (C—F)=3.8 Hz), 126.6 (q, J (C—F)=3.8 Hz), 126.5, 126.2, 123.5 (q, J (C—F)=272.5 Hz), 121.7.

MS (70 eV, EI) m/z (%): 306 (97) [M⁺], 305 (100), 278 (12), 257 (13), 237 (28), 233 (18), 208 (29), 160 (13), 44 (40).

IR (ATR) {tilde over (v)} (cm⁻¹): 3068, 2866, 2359, 1926, 1745, 1669, 1590, 1520, 1483, 1459, 1438, 1421, 1392, 1351, 1325, 1310, 1288, 1265, 1217, 1178, 1156, 1118, 1097, 1092, 1073, 1051, 1018, 1000, 994, 966, 947, 933, 907, 868, 863, 812, 773, 754, 733, 703, 679, 653, 641, 633, 620, 608, 603.

HRMS (EI) for C₁₆H₉F₃OS (306.0326): 306.0326.

Synthesis of 2-(4-chlorophenyl)benzo[b]thiophene-3-carbaldehyde (29b)

Benzo[b]thiophene-3-carbaldehyde (27) (162 mg, 1.0 mmol) in THF (2 mL) was added to a solution of TMPZnCl.LiCl (2) (1.3 M in THF, 0.85 mL, 1.1 mmol) at 25° C. and the reaction mixture was then stirred at this temperature for 30 min according to TP 2. Pd(dba)₂ (17 mg, 3 mol %) and P(o-furyl)₃ (14 mg, 6 mol %) dissolved in THF (2 mL), and mixed with 1-chloro-4-iodobenzene (310 mg, 1.3 mmol, 1.3 equiv) were then transferred via cannula to the reaction mixture. The resulting mixture was stirred for 2 h at 25° C. The reaction mixture was then quenched with a sat. aq. NH₄Cl solution (20 mL), extracted with diethyl ether (3×50 mL) and dried over anhydrous Na₂SO₄. After filtration, the solvent was evaporated in vacuo. Purification by flash-chromatography (CH₂Cl₂/n-pentane, 1:3) furnished compound 29b (236 mg, 87%) as a colourless solid.

m.p.: 99.7-101.4° C.

¹H-NMR (300 MHz, CDCl₃) δ: 10.02 (s, 1H), 8.76 (d, J=8.0 Hz, 1H), 7.83 (d, J=8.0 Hz, 1H), 7.42-7.54 (m, 6H).

¹³C-NMR (75 MHz, CDCl₃) δ: 186.2, 158.9, 137.8, 136.9, 136.4, 131.6, 130.3, 130.0, 129.2, 126.4, 126.0, 125.2, 121.6.

MS (70 eV, EI) m/z (%): 272 (100) [M⁺], 237 (54), 208 (34), 165 (12), 118 (20), 104 (23).

IR (ATR) {tilde over (v)} (cm⁻¹): 3054, 2969, 2867, 2362, 1947, 1739, 1671, 1590, 1562, 1517, 1482, 1457, 1431, 1407, 1397, 1346, 1265, 1218, 1187, 1161, 1135, 1109, 1091, 1050, 1020, 1012, 971, 952, 938, 846, 830, 813, 748, 723, 716, 710, 698, 667, 638, 616, 610, 603.

HRMS (EI) for C₁₅H₉ClOS (272.0063): 272.0057.

Synthesis of 2-(phenylethynyl)benzo[b]thiophene-3-carbaldehyde (29c)

Benzo[b]thiophene-3-carbaldehyde (27) (162 mg, 1.0 mmol) in THF (2 mL) was added to a solution of TMPZnCl.LiCl (2) (1.3 M in THF, 0.85 mL, 1.1 mmol) at 25° C. and the reaction mixture was then stirred at this temperature for 30 min according to TP 2. I₂ (381 mg, 1.5 mmol) dissolved in dry THF (2 mL) was then dropwise added and the resulting mixture was stirred for 0.5 h. To the solution of freshly generated in situ 2-iodobenzo[b]thiophene-3-carbaldehyde, NEt₃ (7 mL), CuI (8 mg, 4 mol %), Pd(dba)₂ (17 mg, 3 mol %) and P(o-furyl)₃ (14 mg, 6 mol %) in THF (2 mL) and phenylacetylene (254 mg, 1.5 mol, 1.5 equiv) were successively slowly added. The reaction mixture was stirred at rt for 2 h. The reaction mixture was quenched with a sat. aq. Na₂S₂O₃ solution (10 mL) and with a sat. aq. NH₄Cl solution (20 mL), extracted with diethyl ether (3×50 mL) and dried over anhydrous Na₂SO₄. After filtration, the solvent was evaporated in vacuo. Purification by flash-chromatography (CH₂Cl₂/n-pentane, 1:2) furnished compound 29c (165 mg, 63%) as a yellowish solid.

m.p.: 104.9-106.5° C.

1H-NMR (400 MHz, CDCl₃) δ: 10.47 (s, 1H), 8.69 (m, 1H), 7.77 (m, 1H), 7.60 (m, 2H), 7.38-7.51 (m, 5H).

13C-NMR (100 MHz, CDCl₃) δ: 185.6, 138.9, 138.5, 135.9, 135.2, 131.8, 129.8, 128.6, 126.8, 126.5, 124.9, 121.6, 121.3, 102.9, 80.0.

MS (70 eV, EI) m/z (%): 262 (100) [M⁺], 234 (38), 232 (13), 202 (11), 189 (13).

IR (ATR) {tilde over (v)} (cm⁻¹): 2969, 2832, 2359, 2340, 2203, 1739, 1661, 1587, 1569, 1507, 1481, 1458, 1442, 1427, 1361, 1316, 1293, 1250, 1229, 1216, 1177, 1162, 1141, 1119, 1070, 1059, 1043, 1015, 997, 953, 918, 868, 748, 737, 697, 687, 668, 630, 621, 616, 610.

HRMS (EI) for C₁₇H₁₀OS (262.0452): 262.0459. 

The invention claimed is:
 1. A compound of formula R¹R²N—ZnY LiY wherein R¹ and R² form together in connection with N to form a cyclic amide structure which is derived from a divalent saturated or unsaturated, linear or branched alkyl, alkenyl or alkynyl moiety; and each Y is independently selected from F, Cl, Br, I, CN, SCN, NCO, HalO₃, HalO₄, NO₃, BF₄, PF₆, H, and NO_(R), wherein n=2 or 3; and wherein Hal is a halogen selected from Cl, Br and I.
 2. The compound of claim 1, wherein the cyclic amide structure has one or more substituents derived from aliphatic, alicyclic, aromatic or heteroaromatic hydrocarbons, and wherein each substituent is bound to the cyclic structure via a carbon atom.
 3. The compound of claim 2, wherein the cyclic amide structure comprises piperidide and wherein each Y is independently selected from F, Cl, Br and I.
 4. The compound of claim 1, wherein each Y is independently selected from F, Cl, Br, and I.
 5. The compound of claim 1, wherein Y is Cl.
 6. A process for the preparation of a compound comprising: reacting R¹R²N—H with a lithium alkyl in the presence of ZnY₂ and a solvent to form the compound having the formula R¹R²N—ZnY LiY, wherein R¹, R² form together in connection with N to form a cyclic amine structure which is derived from a divalent saturated or unsaturated, linear or branched alkyl, alkenyl or alkynyl moiety; and Y is independently selected from F, Cl, Br, I, CN, SCN, NCO, HalO₃, HalO₄, NO₃, BF₄, PF₆, H, and NO_(R), wherein n=2 or 3; and wherein Hal is a halogen selected from Cl, Br and I.
 7. The process of claim 6, wherein the cyclic amine structure has one or more substituents derived from aliphatic, alicyclic, aromatic or heteroaromatic hydrocarbons, and wherein each substituent is bound to the cyclic structure via a carbon atom.
 8. The process of claim 7, wherein the cyclic amine structure comprises piperidine and wherein Y is selected from F, Cl, Br and I.
 9. The process of claim 7, wherein Y is selected from F, Cl, Br, and I.
 10. The process of claim 7, wherein the solvent is selected from cyclic, linear or branched mono or polyethers, thioethers, amines, phosphines, and derivatives thereof containing one or more additional heteroatoms selected from O, N, S and P; cyclic, linear or branched alkanes and/or alkenes wherein one or more hydrogens are replaced by a halogen; urea derivatives; aromatic, hetero aromatic or aliphatic hydrocarbons; CS₂; or combinations thereof.
 11. The process of claim 10, wherein the solvent is selected from cyclic, linear or branched mono or polyethers, thioethers, amines, phosphines, and derivatives thereof containing one or more additional heteroatoms selected from O, N, S and P.
 12. The process of claim 7, wherein the lithium alkyl is sec-butyl lithium or n-butyl lithium.
 13. A process comprising zincating a substrate having a deprotonatable aromatic ring with a compound of formula R¹R²N—ZnY LiY wherein R¹ and R² form together in connection with N to form a cyclic amide structure which is derived from a divalent saturated or unsaturated, linear or branched alkyl, alkenyl or alkynyl moiety; and each Y is independently selected from F, Cl, Br, I, CN, SCN, NCO, HalO₃, HalO₄, NO₃, BF₄, PF₆, H, and NO_(R), wherein n=2 or 3; and wherein Hal is a halogen selected from Cl, Br and I, to form a zincated product.
 14. The process of claim 13, wherein the cyclic amide structure comprises piperidide and wherein Y is selected from F, Cl, Br, and I.
 15. The process of claim 13, wherein the substrate is 3,6-dichloropyridazine, 4,6-dichloropyrimidine, 2,6-dichloropyrazine, caffeine, 2,4-difluoronitrobenzene, 2-chloro-3-nitropyridine, 4-fluoro-1-methoxy-2-nitrobenzene, methyl 5-nitrofuran-2-carboxylate, or benzo[b]thiophene-3-carbaldehyde.
 16. The process of claim 13, further comprising contacting the zincated product and an electrophile.
 17. The process of claim 16, wherein the electrophile is iodine, 1-iodo-3-(trifluoromethyl)-benzene, allyl bromide, furoyl chloride, ethyl 4-iodobenzoate, ethyl 2-(bromomethyl)acrylate, 1-chloro-4-iodo-benzene, or 3-bromocyclohexene. 